The antibiotic valproic acid (Depakote) is an inhibitor of biotransformation. How will this affect the pharmacokinetics of this medication?
a. The ionization of Depakote will slow its absorption.
b. The reduction of CP450 function leaves more active drug in the body.
c. Depakote metabolites are excreted more in the bile than in the urine.
d. The binding of Depakote to blood proteins reduces the activity of the drug.
b
You might also like to view...
What is the expected impact on this condition when disordered eating or an eating disorder is present over many years? Bone density
a. Likely to decline b. Likely to increase c. Not likely to be affected
Medical treatment of hepatitis includes:
a. decreased protein intake. b. antibiotics. c. use of branched-chain amino acids. d. bed rest and optimal nutrition.
Enzymes produced in the salivary glands help to break down:
A) fiber. B) protein. C) fat. D) starch. E) c, d
Conditions associated with the female athlete triad include ________.
A. hyperthermia B. cystic fibrosis C. premenopausal polycystic syndrome D. reduced bone mineral density